Role of certain oral drug, medicated oil through rectal and topical (ear) route in sensorineural hearing loss

A randomized clinical trial on comparative efficacy of Masha Taila Matra Basti and Karnapoorana along with Narsingha Churna orally in the Management of Vataja Badhirya w. s. r. to Sensorineural Hearing Loss

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020096

Enrollment

Registered

2019-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H905- Unspecified sensorineural hearingloss

Interventions

Intervention1: Masha Taila Matra Basti along with Narsingha Churna orally: Masha Taila 60 ml/day will be given in form of matra basti through rectal route for 3 sittings of 8 days with 3 days gap in e

Eligibility

Inclusion criteria

Inclusion criteria: Patients having specific signs and symptoms of Badhirya (SNHL) as per Ayurvedic and modern parameters will be registered.

Exclusion criteria

Exclusion criteria: 1. Patients having congenital hearing loss. 2. Patients having history of long term intake of ototoxic drugs. 3. Pregnant women. 4. Patients suffering from systemic diseases like uncontrolled diabetes mellitus, Tuberculosis, Hypertension, Meniereâ??s disease, Otosclerosis, Labyrinthitis etc. 5. Patients with tympanic membrane perforation. 6. Genetic SNHL. 7. Psychogenic hearing loss. 8. Degree of hearing loss greater than 80 dB.

Design outcomes

Primary

Measure	Time frame
Change in the investigator assessment score for decrease in the degree of hearing lossTimepoint: 2 months	—

Secondary

Measure	Time frame
Any adverse event reported voluntarily,observed or enquiredTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Shamsa Fiaz

National Institute of Ayurveda, Jaipur

shamsa_fiaz@yahoo.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026